LIPO

Lipella Pharmaceuticals Inc. LIPO

LIPO
Lipella Pharmaceuticals Inc. PTIX
Protagenic Therapeutics, Inc. GTBP
GT Biopharma, Inc. AZTR
Azitra, Inc. ARTL
Artelo Biosciences, Inc. NKGN
NKGen Biotech, Inc. Common Stock SLRX
Salarius Pharmaceuticals, Inc. DRMA
Dermata Therapeutics, Inc. VRAX
Virax Biolabs Group Limited INDP
Indaptus Therapeutics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode LIPO PTIX GTBP AZTR ARTL NKGN SLRX DRMA VRAX INDP
6M -87.87 % -65.73 % -74.59 % -81.70 % -71.92 % -80.00 % -96.17 % 223.32 % -50.59 % -72.22 %
YTD -93.71 % -83.22 % -73.64 % -89.86 % -75.23 % -92.76 % -97.47 % 57.19 % -82.25 % -91.22 %
1Y -93.55 % -83.69 % -72.42 % -89.28 % -71.88 % -92.22 % -97.20 % 77.64 % -79.57 % -91.56 %
3Y -99.44 % -95.13 % -97.69 % -99.97 % -91.00 % -99.12 % -99.53 % -94.89 % -93.18 % -95.19 %
5Y -96.52 % -99.04 % -99.70 % -99.97 % -97.12 % -99.12 % -99.97 % -99.82 % -99.78 % -99.53 %
10Y -96.52 % -99.04 % -100.00 % -99.97 % -99.61 % -99.12 % -100.00 % -99.82 % -99.78 % -99.98 %
From the beginning -96.52 % -99.04 % -100.00 % -99.97 % -99.61 % -99.12 % -100.00 % -99.82 % -99.78 % -99.98 %

Dividend

Protagenic Therapeutics, Inc.